Insights On Partnering
-
Canadian CTA Frequently Asked Questions
2/20/2024
This FAQ list offers clarity on pivotal aspects of your drug development journey, ensuring studies in Canada pave the way for U.S. FDA and EMA submissions.
-
2023 Site Payments And Budgeting Market Trends Survey
3/7/2024
Explore the findings from this survey of the global clinical trials market, shedding light on processes, challenges, and preferences associated with global site payments, and more.
-
Faster Trial Planning and Site Selection
4/15/2025
Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.
-
Cell And Gene Therapy Development – 3 Key Challenges In 2023
10/29/2023
Considering the current landscape, here are three critical factors for cell and gene therapy developers to overcome obstacles and advance development.
-
Global Start-Up For Multinational Geographic Atrophy Trial
6/26/2025
This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.
-
The Greatest Impact Of Tax In Clinical Research
5/15/2024
In a recent Site Survey, Greenphire collected site perspectives on taxation in clinical trials and its impact on participants. Here, we review several real-life examples that were shared by survey participants.
-
Uncovering The Root Cause Of Clinical Trial Troubles
12/10/2024
Discover essential strategies to prevent clinical trials from reaching a crisis while gaining a deeper understanding of the importance of addressing systemic issues early.
-
Robust Models For Supporting PV And Medical Information Activity
8/15/2023
Learn how outsourcing local pharmacovigilance and medical information activities to an established safety organization can provide high-quality expertise and technology that meets demand.
-
Tailored Solutions For A Global Phase III Neovascular AMD Study
3/17/2025
How did a Phase III combination study for neovascular age-related macular degeneration (AMD) overcome study complexities while expanding across 16 countries?
-
Successful Manufacturing Of Clinical Trial Supply
8/27/2024
Formulation and pharmacy experts share their secrets for completing clinical trials and resolving issues that could impact your drug development program’s timeline.